PND9 IS GENETIC TESTING IN COMBINATION WITH PREVENTIVE DONEPEZIL (ARICEPT) TREATMENT FOR PATIENTS WITH MILD COGNITIVE IMPAIRMENT COST- EFFECTIVE?
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74016-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)74016-X/fulltext
Section Title :
Section Order :
506
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74016-X&doi=10.1016/S1098-3015(10)74016-X